{"id":1187937,"date":"2025-01-28T17:30:00","date_gmt":"2025-01-28T16:30:00","guid":{"rendered":"https:\/\/ticronometro.com\/wp\/2025\/01\/notizie-rss\/ultima-ora\/malattie-rare-oro-aop-health-italy-reinvestito-in-ricerca-il-10-del-fatturato\/"},"modified":"2025-01-28T18:07:00","modified_gmt":"2025-01-28T17:07:00","slug":"malattie-rare-oro-aop-health-italy-reinvestito-in-ricerca-il-10-del-fatturato","status":"publish","type":"post","link":"https:\/\/ticronometro.com\/wp\/2025\/01\/notizie-rss\/ultima-ora\/malattie-rare-oro-aop-health-italy-reinvestito-in-ricerca-il-10-del-fatturato\/","title":{"rendered":"Malattie rare, Oro (Aop Health Italy): &#8220;Reinvestito in ricerca il 10% del fatturato&#8221;"},"content":{"rendered":"<p>(Adnkronos) &#8211; &#8220;Investiamo in nuove molecole ma anche per continuare lo sviluppo clinico di molecole pi\u00f9 vecchie&#8221;<a href=https:\/\/www.adnkronos.com\/salute\/malattie-rare-oro-aop-health-italy-reinvestito-in-ricerca-il-10-del-fatturato_75FfX9LcT7MsYjz3kBj9r5>Continua la Lettura<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Adnkronos) &#8211; &#8220;Investiamo in nuove molecole ma anche per continuare lo sviluppo clinico di molecole pi\u00f9 vecchie&#8221;<\/p>\n","protected":false},"author":1,"featured_media":162173,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_sitemap_exclude":false,"_sitemap_priority":"","_sitemap_frequency":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[74],"tags":[],"class_list":["post-1187937","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ultima-ora"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/ticronometro.com\/wp\/wp-json\/wp\/v2\/posts\/1187937","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ticronometro.com\/wp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ticronometro.com\/wp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ticronometro.com\/wp\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ticronometro.com\/wp\/wp-json\/wp\/v2\/comments?post=1187937"}],"version-history":[{"count":0,"href":"https:\/\/ticronometro.com\/wp\/wp-json\/wp\/v2\/posts\/1187937\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ticronometro.com\/wp\/wp-json\/wp\/v2\/media\/162173"}],"wp:attachment":[{"href":"https:\/\/ticronometro.com\/wp\/wp-json\/wp\/v2\/media?parent=1187937"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ticronometro.com\/wp\/wp-json\/wp\/v2\/categories?post=1187937"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ticronometro.com\/wp\/wp-json\/wp\/v2\/tags?post=1187937"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}